Great Ormond Street Hospital participates in 44th Congress of the International Society of Paediatric Oncology
- Kuwait: Thursday, October 18 - 2012 at 10:27
- PRESS RELEASE
Great Ormond Street Hospital for Children (GOSH), one of the world's leading centres for treating sick children, recently participated in the 44th Congress of the International Society of Paediatric Oncology (SIOP), which took place in London from 5-8 October 2012.
SIOP is the largest international annual conference on paediatric oncology. It brings together doctors, scientists, nurses and parents in a holistic review of current care standards for children with Cancer. GOSH, which has a partnership with Kuwait's Ministry of Health, had a prominent role in the conference, with its executives and medical experts leading and chairing 11 educational sessions and debates, including: 'Meet the expert on paediatric stem cell transplantation' and 'Sustaining innovation and improvement in childhood cancer treatment around the world'.
"We are proud to continue to support the International Society of Paediatric Oncology and the SIOP conferences," said Professor Kathy Pritchard-Jones. "Ever since GOSH's inception, children's healthcare services, programmes, treatments and developments have always been very important. SIOP provides an important forum for us to share our knowledge and ideas with some of the professionals from across the world."
At the conference, members of the GOSH team delivered detailed presentations about the hospital's work, and the programmes and treatments available to patients and their parents.
GOSH stand reached out to both referral clinicians and visitors who were keen to learn about the hospital's services.
In Kuwait GOSH has established a successful working partnership with NBK Hospital. Senior GOSH medical staff have been providing practical support and training to NBK nurses and doctors which has increased understanding of paediatric procedures, diagnosis and care in a clinical setting. GOSH also provides cutting-edge diagnostic capability to patients in Kuwait through its Minimal Residual Disease (MRD) testing for children with leukemia at NBK hospital.
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / 4C. AME Info FZ LLC / 4C is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.